Tyra Biosciences, Inc.TYRANASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank33
3Y CAGR-49.2%
5Y CAGR-16.1%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-49.2%/yr
Annual compound
5Y CAGR
-16.1%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 23.79% |
| 2024 | 38.29% |
| 2023 | 9.47% |
| 2022 | 181.65% |
| 2021 | 169.91% |
| 2020 | 57.21% |
| 2019 | 0.00% |